Obesity Pill Approved by Fda

FDA, Lilly and weight loss

FDA rethinking block on compounding of Lilly's obesity drug

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to investigate whether shortages of the drug, which is sold by Lilly as Mounjaro for diabetes and Zepbound for obesity, have actually been resolved as reported earlier this month.

Reuters on MSN · 2d

US FDA to reconsider decision barring compounded versions of Lilly weight loss drug

The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly's blockbuster weight loss and diabetes drugs.

Seeking Alpha on MSN · 1d

FDA to review removal of Eli Lilly weight loss drug from shortage list

The U.S. Food and Drug Administration (FDA) has agreed to reconsider its decision to remove tirzepatide, the active ingredient of Eli Lilly's (NYSE:LLY) diabetes therapy Mounjaro and weight loss therapy Zepbound,

STAT · 2d

In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its shortage list.

11monon MSN

FDA approves new obesity drug from Eli Lilly named Zepbound

and that those whose insurance doesn’t cover the drug can get $500 off its $1,350 list price for up to a year. As with ...

Forbes10mon

FDA Approved A New Weight Loss Drug Zepbound. Here’s What To Know And Expect

The FDA recently approved Zepbound, a weekly injectable drug targeted to treat obesity. The medication contains tirzepatide, the same active ingredient that is also present in the diabetes ...

pharmaphorum2d

FDA approves PureTech's obesity device Plenity

The FDA has approved PureTech Health’s ‘space occupying ... This would give it an edge on Novo’s obesity drug Saxenda (liraglutide), whose possible side effects include nausea, diarrhoea ...

Outsourcing-pharma3d

Antag Therapeutics gets FDA clearance to start clinical trials with new obesity drug

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Medpage Today on MSN12d

Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D

The FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...

Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

AOL1mon

Which Medications Are FDA-Approved for Weight Loss?

The U.S. Food and Drug Administration (FDA) has approved seven medications for ... Adults and children over 12 years old living with obesity are eligible to take this drug. Like Saxenda, you ...

Nasdaq1mon

Rhythm Stock Up as FDA Accepts Obesity Drug sNDA for Younger Kids

Rhythm Pharmaceuticals’ RYTM shares gained 8.4% on Aug. 26 after announcing the FDA ... new drug application (sNDA) for its only marketed drug, Imcivree (setmelanotide), to treat obesity ...

Medindia9mon

New Drug to Fight against Obesity

The U.S. Food and Drug Administration (FDA) approved the drug for weight control ... The drug has caused a lot of sensation as it attacks obesity. It was found that people on the drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results